212 related articles for article (PubMed ID: 9876623)
21. Design of a slow-release capsule using laser drilling.
Jain NK; Naik SU
J Pharm Sci; 1984 Dec; 73(12):1806-11. PubMed ID: 6527262
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
Liu JP; Ma X; Zhu JB
Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
[TBL] [Abstract][Full Text] [Related]
23. Phase transited and vapor-induced dual capsular system (DCS) for achieving delayed and osmotic release of cefadroxil.
Philip AK; Philip B
Pharm Dev Technol; 2011 Oct; 16(5):457-65. PubMed ID: 20482448
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo studies of sustained-release floating dosage forms containing salbutamol sulfate.
Babu VB; Khar RK
Pharmazie; 1990 Apr; 45(4):268-70. PubMed ID: 2381979
[TBL] [Abstract][Full Text] [Related]
25. Formulation and release of dihydralazine sulphate from tabletted microcapsules.
Oner L; Yalabik-Kaş HS; Hincal AA
J Microencapsul; 1984; 1(2):123-30. PubMed ID: 6336521
[TBL] [Abstract][Full Text] [Related]
26. In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants.
Elias-Al-Mamun M; Khan HA; Dewan I; Jalil RU
Pak J Pharm Sci; 2009 Oct; 22(4):360-7. PubMed ID: 19783512
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
Goole J; Vanderbist F; Amighi K
Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
[TBL] [Abstract][Full Text] [Related]
28. Bioequivalence of verapamil hydrochloride extended-release pellet-filled capsules when opened and sprinkled on food and when swallowed intact.
Kozloski GD; De Vito JM; Johnson JB; Holmes GB; Adams MA; Hunt TL
Clin Pharm; 1992 Jun; 11(6):539-42. PubMed ID: 1600686
[TBL] [Abstract][Full Text] [Related]
29. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
Cole ET; Cadé D; Benameur H
Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
[TBL] [Abstract][Full Text] [Related]
30. Design and evaluation of a controlled-release theophylline tablet. Preliminary communication.
Gai MN; Pezoa R; Corbeaux J; Arancibia A
Farmaco; 1989 Nov; 44(11):1119-26. PubMed ID: 2701966
[TBL] [Abstract][Full Text] [Related]
31. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture.
Digenis GA; Sandefer EP; Page RC; Doll WJ; Gold TB; Darwazeh NB
Pharm Res; 2000 May; 17(5):572-82. PubMed ID: 10888309
[TBL] [Abstract][Full Text] [Related]
32. The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheres.
Vandelli MA; Forni F; Iannuccelli V; Cameroni R
J Pharm Belg; 1991; 46(6):381-8. PubMed ID: 1783972
[TBL] [Abstract][Full Text] [Related]
33. The influence of additives on the presentation of a drug in hard gelatin capsules.
Newton JM; Razzo FN
J Pharm Pharmacol; 1977 May; 29(5):294-7. PubMed ID: 17694
[TBL] [Abstract][Full Text] [Related]
34. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil.
Philip AK; Pathak K; Shakya P
Eur J Pharm Biopharm; 2008 Jun; 69(2):658-66. PubMed ID: 18206358
[TBL] [Abstract][Full Text] [Related]
35. [Preparation and in vitro release of tetramethylpyrazine phosphate pulsincap capsule controlled by an erodible plug].
Wu F; Zhang ZR; He WL; Zhang Y
Yao Xue Xue Bao; 2002 Sep; 37(9):733-8. PubMed ID: 12567902
[TBL] [Abstract][Full Text] [Related]
36. Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.
Dinarvand R; Mahmoodi S; Farboud E; Salehi M; Atyabi F
Acta Pharm; 2005 Mar; 55(1):57-67. PubMed ID: 15907224
[TBL] [Abstract][Full Text] [Related]
37. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
Sawicki W; Lunio R
Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
[TBL] [Abstract][Full Text] [Related]
38. Effect of sodium bicarbonate and sodium starch glycolate on the in vivo disintegration of hard gelatin capsules--a radiological study in the dog.
Marvola M; Hannula AM; Ojantakanen S; Westermarck E; Rajamäki M
Acta Pharm Nord; 1989; 1(6):355-62. PubMed ID: 2560378
[TBL] [Abstract][Full Text] [Related]
39. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
Garbacz G; Cadé D; Benameur H; Weitschies W
Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
[TBL] [Abstract][Full Text] [Related]
40. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.
Digenis GA; Gold TB; Shah VP
J Pharm Sci; 1994 Jul; 83(7):915-21. PubMed ID: 7965669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
